Geoffrey M. Price Sells 12,500 Shares of Oak Street Health, Inc. (NYSE:OSH) Stock

Oak Street Health, Inc. (NYSE:OSH) COO Geoffrey M. Price sold 12,500 shares of the business’s stock in a transaction on Tuesday, January 11th. The shares were sold at an average price of $25.02, for a total transaction of $312,750.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

NYSE OSH opened at $22.00 on Friday. Oak Street Health, Inc. has a 52 week low of $21.56 and a 52 week high of $66.31. The firm has a market capitalization of $5.30 billion, a P/E ratio of -13.58 and a beta of 1.14. The company has a quick ratio of 2.78, a current ratio of 2.78 and a debt-to-equity ratio of 5.88. The company has a 50-day moving average price of $32.75 and a 200-day moving average price of $44.62.

Oak Street Health (NYSE:OSH) last released its quarterly earnings results on Monday, November 8th. The company reported ($0.49) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.47) by ($0.02). Oak Street Health had a negative net margin of 27.80% and a negative return on equity of 133.13%. The business had revenue of $388.70 million for the quarter, compared to analysts’ expectations of $357.53 million. During the same period in the previous year, the company earned ($0.15) EPS. Oak Street Health’s revenue for the quarter was up 78.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Oak Street Health, Inc. will post -1.83 EPS for the current year.

A number of equities analysts recently issued reports on OSH shares. SVB Leerink dropped their price target on shares of Oak Street Health from $51.00 to $41.00 and set a “market perform” rating on the stock in a research note on Wednesday, November 10th. Cowen cut shares of Oak Street Health from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $48.00 to $25.00 in a research note on Monday, January 10th. Truist dropped their price target on shares of Oak Street Health from $72.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, October 13th. Jefferies Financial Group started coverage on shares of Oak Street Health in a research note on Wednesday, October 20th. They issued a “buy” rating and a $50.00 price target on the stock. Finally, Zacks Investment Research upgraded shares of Oak Street Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 19th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $57.82.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cullen Frost Bankers Inc. purchased a new stake in shares of Oak Street Health during the 3rd quarter valued at about $28,000. CI Investments Inc. purchased a new stake in shares of Oak Street Health during the 3rd quarter valued at about $28,000. Parkside Financial Bank & Trust purchased a new stake in shares of Oak Street Health during the 3rd quarter valued at about $82,000. Captrust Financial Advisors purchased a new stake in shares of Oak Street Health during the 3rd quarter valued at about $89,000. Finally, PNC Financial Services Group Inc. increased its holdings in Oak Street Health by 21,572.7% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,384 shares of the company’s stock worth $140,000 after acquiring an additional 2,373 shares in the last quarter. 85.67% of the stock is owned by hedge funds and other institutional investors.

About Oak Street Health

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Read More: What is a recession?

Insider Buying and Selling by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.